Protease-resistant peptide design-empowering nature's fragile warriors against HIV
about
Improving binding affinity and stability of peptide ligands by substituting glycines with D-amino acidsViral membrane fusion.Development of a membrane-anchored chemerin receptor agonist as a novel modulator of allergic airway inflammation and neuropathic painSynthesis and folding of a mirror-image enzyme reveals ambidextrous chaperone activity.Peptides displayed as high density brush polymers resist proteolysis and retain bioactivity.Cancer cell surface induced peptide folding allows intracellular translocation of drug.Preferential germline usage and VH/VL pairing observed in human antibodies selected by mRNA display.Protein catalyzed capture agents with tailored performance for in vitro and in vivo applications.Peptide Backbone Composition and Protease Susceptibility: Impact of Modification Type, Position, and Tandem Substitution.Design of Stable α-Helical Peptides and Thermostable Proteins in Biotechnology and Biomedicine.Rational, computer-enabled peptide drug design: principles, methods, applications and future directions.Peptide regulation of cofilin activity in the CNS: A novel therapeutic approach for treatment of multiple neurological disorders.Aligator: A computational tool for optimizing total chemical synthesis of large proteins.Design and characterization of ebolavirus GP prehairpin intermediate mimics as drug targets.Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy.Bike peptides: a ride through the membrane.N-Gemini peptides: cytosolic protease resistance via N-terminal dimerization of unstructured peptides.Short proline-rich lipopeptide potentiates minocycline and rifampicin against multidrug- and extensively drug-resistant Pseudomonas aeruginosa.Pharmacokinetic and Chemical Synthesis Optimization of a Potent d-Peptide HIV Entry Inhibitor Suitable for Extended-Release Delivery.Characterization of the PEGylated Functional Upstream Domain Peptide (PEG-FUD): a Potent Fibronectin Assembly Inhibitor with Potential as an Anti-Fibrotic Therapeutic.Bulky Dehydroamino Acids Enhance Proteolytic Stability and Folding in β-Hairpin Peptides.
P2860
Q27685175-A32761A1-E14D-4EAA-8331-5D7743E44F0EQ28080422-EAB45CD8-1C10-40DA-9BF3-140417062944Q33676679-49945258-BCC0-4020-81C5-0DA638A2B135Q34060919-A5EA230D-F7B6-4801-AE5A-F3256B4409DDQ34489488-0CB7728D-AB49-4ADB-937B-3A891478F1F9Q35691164-992A03FE-AA27-41EB-9055-F07B47627238Q35763923-CCB5A182-AF55-4F05-AFF0-80523A1A6761Q36107567-CDF3EF00-DC6B-443E-B05F-CBE022F2D8BDQ36488030-6EF7E973-2684-433A-8F2F-5807F1C4DBECQ37544873-0DA9FF55-3236-4373-BAA0-95AF22774FBEQ38618616-2BA1973C-D199-46A6-AFB1-8F0F95F6F00DQ39148389-B923F0F8-5FA3-408D-A9E4-263AB734A29CQ39399243-4EEC6C28-4F84-489D-8AF0-D11A53C71BDDQ40188132-EAA8852E-F6F3-48EE-89C7-E54F909D88D3Q41016131-E11FED94-1E52-4893-8587-DC9FAC8E2AD0Q48112273-A4917ED2-4342-4071-BAA6-F0C1D3B17D28Q48572712-A9FB1165-BDE8-4759-A0D2-2FFD0ACDAC48Q50044323-5E516E22-15C0-41CD-8C86-B535589CAD8AQ50046992-1E0F808B-A97E-4A3A-A99C-D9412B28A6D5Q52716966-1F4872C5-8F1C-4D64-8BEC-1B7F5E883EC6Q53725826-C8BCE2B8-8042-4968-83FF-CFF8A79E73CB
P2860
Protease-resistant peptide design-empowering nature's fragile warriors against HIV
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Protease-resistant peptide design-empowering nature's fragile warriors against HIV
@ast
Protease-resistant peptide design-empowering nature's fragile warriors against HIV
@en
Protease-resistant peptide design-empowering nature's fragile warriors against HIV
@nl
type
label
Protease-resistant peptide design-empowering nature's fragile warriors against HIV
@ast
Protease-resistant peptide design-empowering nature's fragile warriors against HIV
@en
Protease-resistant peptide design-empowering nature's fragile warriors against HIV
@nl
prefLabel
Protease-resistant peptide design-empowering nature's fragile warriors against HIV
@ast
Protease-resistant peptide design-empowering nature's fragile warriors against HIV
@en
Protease-resistant peptide design-empowering nature's fragile warriors against HIV
@nl
P2093
P2860
P356
P1433
P1476
Protease-resistant peptide design-empowering nature's fragile warriors against HIV
@en
P2093
J. Nicholas Francis
Joseph S. Redman
Matthew T. Weinstock
Michael S. Kay
P2860
P304
P356
10.1002/BIP.22073
P407
P577
2012-01-01T00:00:00Z